[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"kb-reconstitute-peptides-zh":3},{"_path":4,"_dir":5,"_draft":6,"_partial":6,"_locale":7,"title":8,"description":9,"date":10,"dateLabel":11,"updated":12,"read":13,"author":14,"image":15,"faq":16,"body":32,"_type":418,"_id":419,"_source":420,"_file":421,"_stem":422,"_extension":423},"\u002Freconstitute-peptides\u002Fzh","reconstitute-peptides",false,"","肽的复溶：浓度、加水量与保存","复溶到底指什么、mg\u002FmL 的浓度定义怎样用占位符写出来、加多少水为什么是一道测量上的取舍题，以及复溶后的西林瓶该怎么存。","2026-06-22","2026年9月","2026-09-04","8 分钟","myPeptides Team","\u002Fassets\u002Freconstitute-peptides_hero.png",[17,20,23,26,29],{"q":18,"a":19},"“复溶”是什么意思","复溶指的是把无菌液体加到冻干（冷冻干燥）后的固体上，让它溶成一份浓度已知的溶液。这个词出自药品调配领域，适用于任何冻干制剂。",{"q":21,"a":22},"为什么浓度才是关键的那个数","注射器量的是体积，不是质量，所以给定体积里含有多少物质，完全取决于溶液的浓度。浓度就是瓶中的质量除以加入的液体体积，单位是 mg\u002FmL。",{"q":24,"a":25},"多加液体会改变瓶里物质的总量吗","不会。质量在出厂时就已固定；多加液体只是把它摊到更大的体积里、把浓度降下来，于是同样一个量在注射器刻度上占的格数更多。",{"q":27,"a":28},"28 天的配制后使用期限是什么","配制后使用期限指的是：复溶后的制剂过了这段时间，就不再被视为适合使用。对常规生产的多剂量容器，《美国药典》通则〈797〉描述的是自首次穿刺起不超过 28 天，除非标签另有说明。这个数字的前提是抑菌体系还在起作用，而不是靠测量瓶里还剩多少物质得出来的。",{"q":30,"a":31},"复溶后的西林瓶为什么按惯例冷藏保存","进入溶液之后，肽键就暴露在水解、氧化和聚集之下，而这些反应在温度更高时跑得更快。对复溶后的肽制剂，文献描述的惯例是 2–8 °C 冷藏并避光；干粉要稳定得多。",{"type":33,"children":34,"toc":399},"root",[35,44,50,64,71,76,88,93,98,103,108,113,122,127,140,145,150,155,160,178,186,191,196,201,206,211,216,221,233,238,243,253,263,273,285,290,296,300,304,308,312,316,321,325,329,333,338],{"type":36,"tag":37,"props":38,"children":40},"element","h1",{"id":39},"肽的复溶浓度是怎么算出来的",[41],{"type":42,"value":43},"text","肽的复溶：浓度是怎么算出来的",{"type":36,"tag":45,"props":46,"children":47},"p",{},[48],{"type":42,"value":49},"复溶是干粉与可量取的液体之间的那一步。冻干（冷冻干燥）制剂待在胶塞下方，有时是一小块致密的饼，有时只是薄得几乎看不出来的一层膜；干着放的时候它很稳定，因为让它降解的那些反应都需要水。加入确定体积的液体之后，固体就成为一份浓度确定的溶液——而带刻度的注射器读的是浓度，不是标签上那个数字。",{"type":36,"tag":45,"props":51,"children":52},{},[53,55,62],{"type":42,"value":54},"下面要讲的是这个词本身的含义、用占位符写出来的那点算术，以及瓶里有了液体之后随之而来的一串惯例。这些内容都不是在教谁去配什么：这套算术会被套用到的物质里，有不少并未获批为药品，或者属于处方药；凡涉及已获批产品的，以其自身说明书上的说明为准。这一类物质的背景见",{"type":36,"tag":56,"props":57,"children":59},"a",{"href":58},"\u002Fwhat-are-peptides",[60],{"type":42,"value":61},"什么是肽",{"type":42,"value":63},"。",{"type":36,"tag":65,"props":66,"children":68},"h2",{"id":67},"复溶到底指什么",[69],{"type":42,"value":70},"“复溶”到底指什么",{"type":36,"tag":45,"props":72,"children":73},{},[74],{"type":42,"value":75},"复溶指的是把无菌液体加到冻干（冷冻干燥）后的固体上，让它溶成一份浓度已知的溶液。这个词出自药品调配领域，适用于任何冻干制剂；所以口语里说的“配肽”指向的是一件界定清楚的事：已知质量的固体与已知体积的液体混合，得到的结果是一个浓度。",{"type":36,"tag":45,"props":77,"children":78},{},[79,81,87],{"type":42,"value":80},"液体这一项并不能随便换。抑菌注射用水是含有约 0.9% 苯甲醇的无菌水。苯甲醇是抑菌剂，不是灭菌剂：它抑制细菌繁殖，所以这种水在说明书里被描述为适用于多剂量（可多次穿刺）容器。灭菌注射用水不含抑菌成分，被描述为一次性使用的稀释液；两者的逐项对照见",{"type":36,"tag":56,"props":82,"children":84},{"href":83},"\u002Fbacteriostatic-vs-sterile-water",[85],{"type":42,"value":86},"抑菌注射用水与灭菌注射用水",{"type":42,"value":63},{"type":36,"tag":65,"props":89,"children":91},{"id":90},"调配规范描述了什么",[92],{"type":42,"value":90},{"type":36,"tag":45,"props":94,"children":95},{},[96],{"type":42,"value":97},"药典把含抑菌剂与不含抑菌剂的稀释液区分开来，依据是容器按单剂量使用还是按多剂量多次穿刺使用——这是制剂在标签上就已经定下的属性，不是操作台上临时拿的主意。至于配好之后能读到多细，那要看注射器，只取决于它的刻度，与瓶里装了什么无关。",{"type":36,"tag":45,"props":99,"children":100},{},[101],{"type":42,"value":102},"每次穿刺之前对胶塞消毒，属于《美国药典》通则〈797〉所描述的无菌操作；在那套规范里，关键表面是胶塞，而不是针头。",{"type":36,"tag":65,"props":104,"children":106},{"id":105},"唯一的那个公式",[107],{"type":42,"value":105},{"type":36,"tag":45,"props":109,"children":110},{},[111],{"type":42,"value":112},"要用到的等式只有一个，而且它是一条定义，不是一条建议。",{"type":36,"tag":45,"props":114,"children":115},{},[116],{"type":36,"tag":117,"props":118,"children":119},"strong",{},[120],{"type":42,"value":121},"瓶中的质量 ÷ 加入的液体体积 = 浓度",{"type":36,"tag":45,"props":123,"children":124},{},[125],{"type":42,"value":126},"写成占位符：X mg 用 Y mL 复溶，得到的浓度是 X ÷ Y mg\u002FmL；Y 变了，X 一点不变，动的只有浓度。",{"type":36,"tag":45,"props":128,"children":129},{},[130,132,138],{"type":42,"value":131},"读针筒刻度再多两步换算：某个量 Z mg 除以浓度，得到含有这个量的体积（mL）；而在 U-100 胰岛素注射器上 1 mL 就是 100 单位，于是 V mL 对应 V × 100 单位——这套刻度怎么印、怎么读，写在",{"type":36,"tag":56,"props":133,"children":135},{"href":134},"\u002Finsulin-syringe-units",[136],{"type":42,"value":137},"读懂 U-100 胰岛素注射器的刻度",{"type":42,"value":139},"里。整套下来都是单位换算，它既说不出瓶里装的是哪种物质，也说不出多少量才合适。",{"type":36,"tag":45,"props":141,"children":142},{},[143],{"type":42,"value":144},"瓶中的质量在出厂时就已经定死。加液体只是把它摊到更大的体积里，于是同样一个量在刻度上占的格数更多。",{"type":36,"tag":65,"props":146,"children":148},{"id":147},"加水量如何改变浓度",[149],{"type":42,"value":147},{"type":36,"tag":45,"props":151,"children":152},{},[153],{"type":42,"value":154},"没有哪一个体积是唯一正确的，因为这里要定的是一个取舍，而不是一个事实。加得少，溶液就浓，任何一个量在刻度上都只占很短一段，而贴着量程最下端的读数，相对误差很大。加得多，同样的量就摊在更多格刻度上。",{"type":36,"tag":45,"props":156,"children":157},{},[158],{"type":42,"value":159},"范围的两端各有一条边界：溶液太浓，读数被推进针筒上最不准的那一段；太稀，需要的体积又可能超出注射器的容量。这里起作用的道理属于计量学，不属于药学——落在量程中段的读数，相对误差小于挤在两端的读数。",{"type":36,"tag":45,"props":161,"children":162},{},[163,169,171,177],{"type":36,"tag":56,"props":164,"children":166},{"href":165},"\u002Fcalculator",[167],{"type":42,"value":168},"复溶计算器",{"type":42,"value":170},"把这套换算当作单位换算来跑。单位本身见 ",{"type":36,"tag":56,"props":172,"children":174},{"href":173},"\u002Fmg-ml-iu",[175],{"type":42,"value":176},"mg、mL 与 IU",{"type":42,"value":63},{"type":36,"tag":45,"props":179,"children":180},{},[181],{"type":36,"tag":182,"props":183,"children":185},"img",{"alt":184,"src":15},"浓度等于瓶中的质量除以加入的液体体积，以及以单位标注刻度的 U-100 针筒",[],{"type":36,"tag":65,"props":187,"children":189},{"id":188},"这个过程在文献里是怎么被描述的",[190],{"type":42,"value":188},{"type":36,"tag":45,"props":192,"children":193},{},[194],{"type":42,"value":195},"在操作这一层，各家药学资料的说法相当一致，而且读起来更像化学，不像一份动作清单。",{"type":36,"tag":45,"props":197,"children":198},{},[199],{"type":42,"value":200},"《美国药典》通则〈797〉把两个胶塞的消毒、以及等消毒剂挥发干透，都算作无菌操作的一环，因为抑菌作用系于挥发，而不只是接触。制剂文献之所以会提到加液的方向，理由同样出在化学上：一股水柱直冲冻干饼，既产生剪切力，又造出气液界面，而 Wang 与 Roberts（2018）把这两样都列为蛋白在溶液中形成聚集体的途径。因此，关于溶解这一步的描述，说的都是静置或者轻轻打旋——在这两种条件下，剪切力和气液界面都不会出现。",{"type":36,"tag":45,"props":202,"children":203},{},[204],{"type":42,"value":205},"摇晃是最典型的错误，因为它产生泡沫，而泡沫意味着大片的气液界面，蛋白就在那里舒展、聚集。溶解通常几分钟就完成，个别制剂要久一些；文献里说可以使用的溶液，是澄清的，看不到颗粒。《美国药典》通则〈790〉（注射剂中的可见异物）描述的是对着明亮背景的目视检查，《中国药典》通则 0904“可见异物检查法”对应的是同一件事；仍旧发浑、或者能看到未溶解残渣的制剂，不符合这条描述。",{"type":36,"tag":65,"props":207,"children":209},{"id":208},"复溶后的西林瓶怎么保存",[210],{"type":42,"value":208},{"type":36,"tag":45,"props":212,"children":213},{},[214],{"type":42,"value":215},"干粉好伺候，溶液就不同了。瓶里一旦有了水，水解、氧化、脱酰胺和聚集就都可能发生，而这些反应的速率随温度上升。",{"type":36,"tag":45,"props":217,"children":218},{},[219],{"type":42,"value":220},"对复溶后的肽与蛋白制剂，文献描述的惯例是 2–8 °C 冷藏并避光。家用冰箱的门架是整台冰箱里最暖、波动也最大的位置；2–8 °C 这个区间说的是冷藏室内部，不是门上的搁架。",{"type":36,"tag":45,"props":222,"children":223},{},[224,226,232],{"type":42,"value":225},"第二条惯例是配制后使用期限。对常规生产的多剂量容器，《美国药典》通则〈797〉描述的是自首次穿刺起不超过 28 天，除非标签另有说明——这就是坊间那句“大概四周”的出处。关于这个数字，有两点经常被读反：它是一条上限，不是一句承诺；而且它成立的前提是抑菌体系还在起作用，而不是靠测量瓶里还剩多少物质。不含抑菌剂的稀释液根本没有这样一段期限。冷冻是另一回事：冻融循环是有文献记载的聚集诱因，而冻干是工业流程，家里的冷冻室复制不出来。与此相关的问题见",{"type":36,"tag":56,"props":227,"children":229},{"href":228},"\u002Fstoring-peptides-in-syringes",[230],{"type":42,"value":231},"把肽存放在注射器里",{"type":42,"value":63},{"type":36,"tag":65,"props":234,"children":236},{"id":235},"常见的失效方式",[237],{"type":42,"value":235},{"type":36,"tag":45,"props":239,"children":240},{},[241],{"type":42,"value":242},"出问题的情形，大多能归进三类。",{"type":36,"tag":45,"props":244,"children":245},{},[246,251],{"type":36,"tag":117,"props":247,"children":248},{},[249],{"type":42,"value":250},"溶解过程中的机械损伤",{"type":42,"value":252},"。把稀释液直冲到冻干饼上，以及摇晃容器，都会带来剪切力和泡沫。这种损伤看不出来：体积没变，标签上还是那些字，而一部分物质已经离开了溶液。",{"type":36,"tag":45,"props":254,"children":255},{},[256,261],{"type":36,"tag":117,"props":257,"children":258},{},[259],{"type":42,"value":260},"无菌链断掉",{"type":42,"value":262},"。没消毒的胶塞、把不含抑菌剂的稀释液用在多剂量容器上、以及超过使用期限还留着的瓶子，说到底是同一件事的三种写法：在调配规范里，决定一个容器能否多次穿刺使用的是抑菌体系，不是针头。",{"type":36,"tag":45,"props":264,"children":265},{},[266,271],{"type":36,"tag":117,"props":267,"children":268},{},[269],{"type":42,"value":270},"算式与瓶里的东西对不上",{"type":42,"value":272},"。注射器量的是体积，它不可能知道里面溶的是什么；因此，只要对质量的假设一开始就错了，之后每一次读数都会按同一个倍数错下去。标签惯例正是冲着这一点来的：瓶身上记着复溶日期和浓度，这两个数字随时可以拿来对照。",{"type":36,"tag":45,"props":274,"children":275},{},[276,278,284],{"type":42,"value":277},"还有第四类，落在本文话题的边上——把几份配液抽进同一支注射器，见",{"type":36,"tag":56,"props":279,"children":281},{"href":280},"\u002Fmixing-peptides",[282],{"type":42,"value":283},"多种肽共用一支注射器",{"type":42,"value":63},{"type":36,"tag":65,"props":286,"children":288},{"id":287},"常见问题",[289],{"type":42,"value":287},{"type":36,"tag":291,"props":292,"children":294},"h3",{"id":293},"复溶是什么意思",[295],{"type":42,"value":18},{"type":36,"tag":45,"props":297,"children":298},{},[299],{"type":42,"value":19},{"type":36,"tag":291,"props":301,"children":302},{"id":21},[303],{"type":42,"value":21},{"type":36,"tag":45,"props":305,"children":306},{},[307],{"type":42,"value":22},{"type":36,"tag":291,"props":309,"children":310},{"id":24},[311],{"type":42,"value":24},{"type":36,"tag":45,"props":313,"children":314},{},[315],{"type":42,"value":25},{"type":36,"tag":291,"props":317,"children":319},{"id":318},"_28-天的配制后使用期限是什么",[320],{"type":42,"value":27},{"type":36,"tag":45,"props":322,"children":323},{},[324],{"type":42,"value":28},{"type":36,"tag":291,"props":326,"children":327},{"id":30},[328],{"type":42,"value":30},{"type":36,"tag":45,"props":330,"children":331},{},[332],{"type":42,"value":31},{"type":36,"tag":65,"props":334,"children":336},{"id":335},"这些惯例的出处",[337],{"type":42,"value":335},{"type":36,"tag":339,"props":340,"children":341},"ul",{},[342,355,366,377,388],{"type":36,"tag":343,"props":344,"children":345},"li",{},[346,348],{"type":42,"value":347},"《美国药典》通则〈797〉“药品调配——无菌制剂”：无菌操作、胶塞消毒、配制后使用期限。",{"type":36,"tag":56,"props":349,"children":353},{"href":350,"rel":351},"https:\u002F\u002Fwww.usp.org\u002Fcompounding\u002Fgeneral-chapter-797",[352],"nofollow",[354],{"type":42,"value":350},{"type":36,"tag":343,"props":356,"children":357},{},[358,360],{"type":42,"value":359},"《美国药典》通则〈790〉“注射剂中的可见异物”：制剂中可见异物的目视检查；《中国药典》通则 0904“可见异物检查法”为对应章节。",{"type":36,"tag":56,"props":361,"children":364},{"href":362,"rel":363},"https:\u002F\u002Fwww.usp.org\u002F",[352],[365],{"type":42,"value":362},{"type":36,"tag":343,"props":367,"children":368},{},[369,371],{"type":42,"value":370},"抑菌注射用水（USP）产品标签：0.9% 苯甲醇；不含抑菌剂的灭菌注射用水为一次性使用。",{"type":36,"tag":56,"props":372,"children":375},{"href":373,"rel":374},"https:\u002F\u002Fdailymed.nlm.nih.gov\u002F",[352],[376],{"type":42,"value":373},{"type":36,"tag":343,"props":378,"children":379},{},[380,382],{"type":42,"value":381},"Manning MC、Chou DK、Murphy BM、Payne RW、Katayama DS：Stability of protein pharmaceuticals — an update.《Pharmaceutical Research》27(4):544–575（2010）：水解、脱酰胺与聚集是溶液中的降解途径。",{"type":36,"tag":56,"props":383,"children":386},{"href":384,"rel":385},"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F20143256\u002F",[352],[387],{"type":42,"value":384},{"type":36,"tag":343,"props":389,"children":390},{},[391,393],{"type":42,"value":392},"Wang W、Roberts CJ：Protein aggregation — mechanisms, detection, and control.《International Journal of Pharmaceutics》550(1–2):251–268（2018）：剪切力、气液界面与冻融循环是聚集途径。",{"type":36,"tag":56,"props":394,"children":397},{"href":395,"rel":396},"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F30145245\u002F",[352],[398],{"type":42,"value":395},{"title":7,"searchDepth":400,"depth":400,"links":401},2,[402,403,404,405,406,407,408,409,417],{"id":67,"depth":400,"text":70},{"id":90,"depth":400,"text":90},{"id":105,"depth":400,"text":105},{"id":147,"depth":400,"text":147},{"id":188,"depth":400,"text":188},{"id":208,"depth":400,"text":208},{"id":235,"depth":400,"text":235},{"id":287,"depth":400,"text":287,"children":410},[411,413,414,415,416],{"id":293,"depth":412,"text":18},3,{"id":21,"depth":412,"text":21},{"id":24,"depth":412,"text":24},{"id":318,"depth":412,"text":27},{"id":30,"depth":412,"text":30},{"id":335,"depth":400,"text":335},"markdown","content:reconstitute-peptides:zh.md","content","reconstitute-peptides\u002Fzh.md","reconstitute-peptides\u002Fzh","md"]